Results and discussion
In order to examine whether Akt is a target for SCFinduced PI 3-kinase activation, human embryonic kidney (HEK) 293 cells were transiently cotransfected with wildtype Kit/SCF-R and wild-type or mutant hemagglutinin (HA)-tagged Akt constructs. The cells were incubated with or without SCF and Akt was immunoprecipitated and subjected to an in vitro kinase assay using histone H2B as a substrate. SCF stimulated a robust activation of Akt ( Figure 1a ). An activated mutant of Akt, E40K-Akt, displayed increased SCF-stimulated activity compared with that of wild-type Akt, whereas a kinase-inactive mutant, K179M-Akt [13] , was devoid of any activity. We have previously identified an SCF-stimulated feedback loop involving PKC which inhibits receptor signaling by phosphorylating two Kit/SCF-R serine residues, Ser741 and Ser746 [8, 9] . Accordingly, mutation of Ser741 and Ser746 to alanine residues creates a gain-of-function mutant of Kit/SCF-R, S741/746A-Kit, that exhibits increased activation of PI 3-kinase and mitogenesis [2, 8, 9] . Using this mutant, SCF-stimulated activation of Akt was significantly increased, whereas a drastic decrease was observed with the Y721F-Kit mutant which cannot bind to PI 3-kinase ( Figure 1b ). The PI 3-kinase inhibitor wortmannin inhibited the SCF-stimulated activation of Akt by Activation of Akt by different Kit/SCF-R mutants parallels their activation of PI 3-kinase. HEK 293 cells were transiently cotransfected with DNA constructs expressing wild-type (WT) or mutant forms of HA-Akt together with wild-type or mutant forms of Kit. (a) HA-Akt proteins were immunoprecipitated and subjected to an in vitro kinase assay using histone H2B as a substrate. Proteins were immunoblotted with an anti-HA monoclonal antibody (upper panel), and relative phosphorylation of histone H2B (lower panel) was quantitated by phosphorimager analysis. 
Current Biology H2B 80-90%, both in wild-type and mutant Kit/SCF-Rexpressing cells (Figure 1b) . Wortmannin also reduced the basal activity of Akt in unstimulated cells. Thus, SCFstimulated activation of Akt depends on the activation of PI 3-kinase.
It was shown recently that Akt mediates insulin-like growth factor-1 (IGF-1)-promoted neuronal cell survival in a manner dependent on PI 3-kinase [14] , and that the pro-apoptotic molecule Bad becomes inactivated by phosphorylation on Ser112 and Ser136 in response to interleukin-3 (IL-3) [15] . These two serine residues in Bad reside within an Akt phosphorylation consensus sequence RXRxySz, where S is the phosphorylated amino acid residue, X is any amino acid, x and y are small residues and z is a hydrophobic residue [16, 17] . GST -WT Bad S112A-Bad S136A-Bad S112/136A-Bad
Bad, [ 32 P]orthophosphate-labeling of transfected cells was performed. In unstimulated cells, wild-type Bad exhibited basal phosphorylation ( Figure 2d ). SCF treatment of cells stimulated an upward shift of Bad, concurrent with a twofold increase in the total Bad phosphorylation. The band shift induced by SCF was abolished when cells were pretreated with wortmannin. No phosphorylation was detectable in the S112/136A-Bad mutant. As simultaneous phosphorylation of Bad on both Ser112 and Ser136 is required to induce a band shift in response to IL-3 [15] , and as Bad exhibited basal phosphorylation in resting cells, this result is most compatible with Bad being phosphorylated preferentially on one of these two sites in resting cells and the other site being phosphorylated in response to the ligand-stimulated PI-3-kinase-dependent signal. To examine whether Akt can phosphorylate Bad directly, fusion proteins containing bacterially expressed glutathione-S-transferase (GST) and Bad proteins were purified and used as substrates for Akt in an in vitro kinase reaction ( Figure 2e ). HA-Akt immunoprecipitated from transfected cells was able to phosphorylate Bad in vitro, and this phosphorylation was further enhanced by coexpression of p110*. Wortmannin pretreatment of cells efficiently inhibited the phosphorylation of Bad by Akt. Interestingly, Akt phosphorylated S112A-Bad with similar efficiency to wild-type Bad, whereas it did not phosphorylate S136A-Bad or S112/136A-Bad at all. Thus, we conclude that Akt phosphorylates Bad directly in cells on Ser136.
To test for an interaction between Akt and Bad, we performed GST 'pull-down' assays, which showed that wildtype or mutant GST-Bad proteins bound Akt from cell extracts (see Supplementary material). To examine the subcellular localization of Bad and Akt by confocal microscopy, HeLa cells were transiently cotransfected with HA-tagged Akt and Bad ( Figure 3 ; see Supplementary material for control immunostaining). In unstimulated cells, Akt and Bad were evenly distributed throughout the cytoplasm, and Bad was also localized in the nucleus. After SCF stimulation, however, Bad and Akt translocated and colocalized in the perinuclear region. These data suggest that Bad and Akt can physically interact in vivo.
In order to examine the role of the Akt-mediated phosphorylation of Ser136 in Bad in SCF-promoted cell survival, we performed apoptosis assays. U2-OS cells were cotransfected with Kit and Bad constructs together with a green fluorescent protein (GFP) expression construct to allow the detection of transfected cells. After 12 h serum starvation, Bad induced apoptosis in the absence of SCF (Figure 4 ). The few GFP-positive cells still adhering to the dish had fragmented, pycnotic nuclei and the cells were small and rounded up. In the presence of SCF, most transfected cells looked healthy, with oval, normal-sized nuclei and normal cell shape and size, and as only a few dead cells were observed, the number of GFP-positive (adherent) cells per field was higher. SCF was unable to promote survival in cells transfected with either S112/136A-Bad or S136A-Bad, whereas it still promoted survival in S112A-Bad-transfected cells to the same extent as in wild-type-Bad-transfected cells. In cells transfected with Y721F-Kit, SCF was largely unable to rescue cells from apoptosis. In cells transfected with the gain-of-function mutant S741/746A-Kit, SCF had an increased protective effect compared to that of SCF in wild-type Kit-transfected cells, and no dead cells were observed. Cells transfected with only wild-type or mutant Kit receptors, and no Bad, showed no signs of apoptosis ( Figure 4 and data not shown; see Supplementary material for a quantitation of the extent of apoptosis). These results clearly showed that SCF suppressed Bad-induced apoptosis in a PI-3-kinase/Akt-dependent manner, and that this suppression depended on phosphorylation of Ser136 in Bad.
Two recent reports, published while this work was in progress, also concluded that Akt phosphorylates Bad [18, 19] . It has been reported that phosphorylation on Brief Communication 781 
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Ser112 and/or Ser136 in Bad causes binding to the 14-3-3τ protein, leading to its cytosolic sequestration and dissociation from Bcl-X L [15] . Released Bcl-X L may then associate with Bax to promote cell survival (see Supplementary material for a model of SCF-promoted PI-3-kinase-dependent cell survival that involves suppression of Badinduced cell death).
Recently, naturally occurring gain-of-function mutants of Kit have been implicated in several human malignant tumors [11, 12] . Our results with the S741/746A-Kit gainof-function mutant suggest that deregulated PI 3-kinase/Akt activity and thereby enhanced cell survival by suppression of Bad (or other pro-apoptotic factors) might be causally involved in the Kit-induced tumors.
Supplementary material
Methodological detail, a 
Materials and methods

Site directed mutagenesis and plasmid constructs
Mutations were introduced into the human c-kit cDNA using the Altered Sites in vitro mutagenesis system (Promega) according to the manufacturer's instructions. Mutant and wild-type constructs were cloned into the CMV-based mammalian expression vector pcDNA3 (Invitrogen). The cDNA encoding HA-tagged murine wild-type Akt in the pCMV6 vector (HA-Akt/pCMV6) was used to generate HA-Akt-K179M/pCMV6 and HA-Akt-E40K/pCMV6 constructs [S1]. Fulllength murine Bad in the Friend spleen focus forming virus 5' long terminal repeat driven vector pSFFV (Bad/pSFFV) was used to generate the mutant expression plasmids Bad-S112A/pSFFV, Bad-S136A/pSFFV and Bad-S112/136A/pSFFV [S2] . All mutations above were verified by DNA sequencing. Constitutively active p110 (p110*) was made by fusing the inter SH2 domain of p85 to the amino-terminus of Myc-tagged p110 by a 'glycine kinker', and was expressed in a CMV-driven mammalian expression vector [S3] . The pEGFP C1 plasmid encoding GFP was from Clontech. Plasmid constructs encoding GST fusions of Bad, Bad-S112, Bad-S136 and Bad-S112/136A were made by cloning full-length wild-type or mutant Bad from the corresponding pSFFV constructs into pGEX KG [S4] . Briefly, a 560 bp NcoI-EcoRI fragment covering the open reading frame of Bad was blunted and cloned into a blunted NcoI-HindIII digest of pGEX-KG. This fuses GST in-frame to the initiation methionine at the amino terminus of Bad with an intervening glycine kinker. GST-Elk-1 has been described earlier [S5] .
Reagents and antibodies
The mouse monoclonal antibody 12CA5 against the HA tag was from Boehringer Mannheim. Hamster monoclonal antibody 2G11.3.3 recognizing murine Bad was a kind gift from Stanley Korsmeyer (Howard Hughes Medical Institute, Washington University, St. Louis) and was also purchased from Pharmingen. The rabbit polyclonal antiserum N 20 against the amino terminus of Bad was from Santa Cruz Biotechnology. Affinity purified rabbit polyclonal antibodies against human Kit were prepared as described [S6] . Texas red conjugated goat anti mouse IgG (H+L) and FITC-conjugated goat anti-rabbit IgG were from Southern Biotechnology Associates. Horseradish peroxidase (HRP) conjugated donkey anti-rabbit and HRP-conjugated rabbit anti-mouse antibodies were from Amersham and Dakopatts, respectively. Histone H2B was from Boehringer Mannheim, wortmannin and staurosporine from Calbiochem. Reduced glutathione, glutathione agarose and 4',6 diamidino 2 phenylindole (DAPI) were purchased from Sigma. Recombinant human SCF was kindly provided by Amgen.
Expression and purification of GST fusion proteins
The pGEX constructs were transformed into BL21 bacteria. Four hours after addition of IPTG, fusion proteins were released by sonication in lysis buffer, affinity purified on glutathione beads and eluted with reduced glutathione, essentially as described [S4] . For GST 'pull down' assays, glutathione was removed from the purified proteins by dialysis in TBS (50 mM Tris HCl pH 8, 137 mM NaCl, 2.7 mM KCl, 1 mM dithiothreitol and 100 µM PMSF). 
Cell culture and transfection assays
Immunoprecipitation, in vitro kinase assay and immunoblotting
Transiently transfected, serum starved cells were either left untreated or stimulated with SCF (150 ng/ml) for 7 min at 37 o C. Where indicated, wortmannin (100 nM final concentration) was added 1 h before stimulation. For immunoprecipitation of Bad or Kit proteins, cells were lysed in a hypotonic lysis buffer containing 1% Triton X-100, 20 mM Tris HCl pH 7.4, 80 mM NaCl, 5 mM EDTA, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride, 10 µg/ml leupeptin, 10 µg/ml aprotinin, 30 mM Na 4 P 2 O 7 , 250 µM Na 3 VO 4 , 50 mM NaF, 40 µM phenylarsine oxide; for immunoprecipitation of Akt, cells were lysed as described [S1]. After centrifugation of the lysate at 14,000 g for 15 min at 4 o C, supernatants were incubated for 2 h at 4 o C with either 1 µl anti-HA monoclonal antibody (12CA5), 1 mg/ml of monoclonal antibody against murine Bad (2G11) or 1 mg/ml of affinity purified antibodies against Kit as indicated. For subsequent separation on SDS-polyacrylamide gel, immunocomplexes were collected on protein A-Sepharose beads and washed in lysis buffer and in high salt buffer (HSB; lysis buffer containing 500 mM NaCl). Samples were then denatured by addition (1:1 volume) of 2× Laemmli SDS sample buffer and boiling for 3 min. Proteins were separated by 12% SDS-polyacrylamide gel electrophoresis and electrotransferred to polyvinylidene difluoride membrane (Immobilon; Millipore) using wet transfer blotting apparatus (Biorad) or semidry transfer with the Milliblot apparatus (Millipore). Membranes were exposed on a PhosphorImager (Molecular Dynamics) and immunoblotted as described below.
For in vitro kinase assays, samples containing Akt were processed as described [S1]. Briefly, immunocomplexes were washed three times in lysis buffer, once in 20 mM Hepes pH 7.4, and once in kinase buffer without ATP (20 mM Hepes pH 7.4, 1 mM dithiothreitol, 10 mM MnCl 2 , 10 mM MgCl 2 ). Kinase assays were performed for 15 min at room temperature in the presence of [γ-32 P]ATP with either 100 µg/ml histone H2B or 40 µg/ml of GST-Bad protein as substrate. Proteins were boiled in Laemmli SDS sample buffer and separated by 15% SDS-polyacrylamide gel electrophoresis before transfer to PVDF membrane. Immunoblotting was performed using the enhanced chemiluminescence (ECL) system (Amersham). Bad protein was detected with N-20, and HA-Akt with 12CA5 as primary antibodies, respectively.
[ 32 P]orthophosphate labeling of intact cells
HEK293 cells seeded in 6 cm dishes were transiently transfected with 3 µg of the indicated Bad cDNA expression constructs together with 4 µg of Kit wild-type cDNA construct. After 36 h, serum-starved cells were labeled with 1 mCi/ml [ 32 P]orthophosphate in phosphate-free medium for 5 h and processed for immunoprecipitation as described [S6] using 1 µg monoclonal antibody to murine Bad (2G11) for 2 h at 4 o C. Where indicated, wortmannin was added to the labeling medium at 100 nM final concentration during the last hour of labeling. After SDS-polyacrylamide electrophoresis in 12% separating gel, proteins were electrotransferred to PVDF membrane, and the membrane exposed on a PhosphorImager (Molecular Dynamics) and to film. 
Glutathione-S-transferase fusion protein binding assays
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amounts of wild-type or mutant GST-Bad (1 µg/reaction) were then incubated with lysates from the HEK293 cells normalized for protein content. After 2 h incubation at 4 o C, 30 ml glutathione agarose beads (1:1 slurry) were added and the incubation continued for another 30 min. Protein complexes were then washed three times in reducing lysis buffer, denatured by boiling in Laemmli SDS sample buffer and applied to a 10% SDS-polyacrylamide gel. Proteins were electrotransferred to PVDF membrane and probed with the anti-HA monoclonal antibody 12CA5 followed by HRP-conjugated rabbit anti-mouse antibodies (DAKO), and detected using enhanced chemiluminescence (Amersham).
Apoptosis assays
Cell were seeded on 15 mm glass coverslips in 12-well plates and transfected on the following day with the Kit and Bad constructs together with a plasmid, pEGFP C1, encoding GFP. Forty eight hours after transfection, cells were washed three times in serum-free medium and then incubated in 0.1% FBS in DMEM with SCF (150 ng/ml) or vehicle for 8 h. After a brief rinse in phosphate-buffered saline (PBS) cells were fixed for 10 min at room temperature in 3% paraformaldehyde, 2% sucrose, washed twice in PBS and permeabilized by incubation for 5 min in ice-cold Triton X-100 permeabilization solution (0.5% Triton X-100 in 20 mM Hepes pH 7.4, 50 mM NaCl, 3 mM MgCl 2 , 300 mM sucrose). Permeabilization solution was removed by several washes in PBS and nuclei stained with 50 mg/ml DAPI for 5 min on ice. Finally, cells were washed three times in PBS and coverslips mounted on microscope slides. Cells were placed under a fluorescence microscope and photomicrographs taken of identical fields using filters for DAPI and FITC. At least 400 GFP-positive cells were scored for each sample, except in cases where cells had undergone extensive apoptosis where all GFP-positive cells still attached on the coverslip were scored (120-150 cells).
Immunofluorescent staining
Cells seeded on 15 mm coverslips were cotransfected with wild-type Bad and HA-Akt constructs. Forty eight hours after transfection, cells were fixed and permeabilized as described above, and then incubated with a mix of rabbit anti-Bad (N-20) and mouse anti-HA (12CA5) antibodies (1 mg/ml each) for 1 h at room temperature. Cell were rinsed three times in PBS and then incubated for another 1 h with a mixture of FITC-conjugated goat anti-rabbit and Texas red conjugated goat antimouse secondary antibodies. Cells were washed extensively in PBS and mounted on microscope slides before confocal microscopy. The values obtained were based on morphological criteria for apoptosis as described in the text. For each condition, 100 GFPpositive cells were counted in three different fields, and the average number of apoptotic cells determined and expressed as a percentage. The values are the mean of two different experiments.
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Figure 1
Bad and Akt interaction in vitro. (a) Cell lysates were prepared from HEK 293 cells transfected with a construct encoding HA-Akt, and aliquots incubated with 1 µg each of the purified wild-type or mutant GST-Bad fusion proteins or GST alone. The GST fusion proteins were precipitated with glutathione-agarose beads and bound Akt proteins revealed by immunoblotting using the anti-HA 12CA5 monoclonal antibody and enhanced chemiluminescence detection. (b) HEK 293 cells were transfected with constructs encoding HA-tagged versions of either wild-type (WT) Akt, E40K-Akt, K179M-Akt or Erk1 or empty vector (mock). Cell lysates were then used in GST pull-down assays as described in the Materials and methods section. 
